Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...

The FDA determined the data from STARGLO did not provide sufficient evidence to support approving glofitamab-gxbm (Columvi) in combination with gemcitabine and oxaliplatin to treat relapsed/refractory ...

BookMarx will donate a dollar to the GLO Center for each copy of "Chappell Roan: A Little Golden Book Biography" sold.

Glo Bash in Memphis is expected to a triumphant celebration not just of GloRilla, but also of the continuing success of Yo ...